-
Ledipasvir/sofosbuvir, sold
under the
trade name
Harvoni among others, is a
medication used to
treat hepatitis C. It is a fixed-dose
combination of ledipasvir...
-
Ledipasvir is a drug for the
treatment of
hepatitis C that was
developed by
Gilead Sciences.
After completing Phase III
clinical trials, on
February 10...
- glecaprevir/pibrentasvir or
ledipasvir/sofosbuvir (with the
aforementioned limitations for the
latter as above) or 12 w****s of elbasvir/grazoprevir,
ledipasvir/sofosbuvir...
-
hepatitis B in
those who have been
previously infected. In
combination with
ledipasvir,
daclatasvir or simeprevir, it is not
recommended with
amiodarone due...
- HIV/AIDS,
hepatitis B,
hepatitis C, influenza, and COVID-19,
including ledipasvir/sofosbuvir and sofosbuvir.
Gilead is a
member of the Nasdaq-100 and the...
-
Sofosbuvir Sofosbuvir/velpatasvir (sofosbuvir + velpatasvir)
Ledipasvir/sofosbuvir (
ledipasvir + sofosbuvir)
Ribavirin Diloxanide Metronidazole Amphotericin...
- Wong,
David K.; Dieterich, Douglas; Sulkowski, Mark (August 20, 2015). "
Ledipasvir and
Sofosbuvir for HCV in
Patients Coinfected with HIV-1". New England...
-
coadministered with
ritonavir May
increase tenofovir concentrations.
Ledipasvir/sofosbuvir May
increase tenofovir concentrations.
Consider alternative...
- telaprevir, boceprevir, simeprevir, and
others NS5A inhibitors,
including ledipasvir, daclatasvir, and
others NS5B inhibitors,
including sofosbuvir, dasabuvir...
- been approved,
among them
notably the
first FDA-approved NS5A
inhibitor ledipasvir,
approved October 2014 in
combination with
sofosbuvir to
comprise the...
